PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 202 filers reported holding PTC THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,940,036 | -35.9% | 220,439 | +16.2% | 0.01% | -33.3% |
| Q2 2023 | $7,712,494 | -33.6% | 189,636 | -21.0% | 0.02% | -34.8% |
| Q1 2023 | $11,621,528 | +24.0% | 239,916 | -2.3% | 0.02% | +21.1% |
| Q4 2022 | $9,373,749 | -20.9% | 245,579 | +4.0% | 0.02% | -26.9% |
| Q3 2022 | $11,849,000 | +19.8% | 236,082 | -4.4% | 0.03% | +30.0% |
| Q2 2022 | $9,890,000 | +21.1% | 246,935 | +12.8% | 0.02% | +42.9% |
| Q1 2022 | $8,169,000 | -15.9% | 218,991 | -10.2% | 0.01% | -12.5% |
| Q4 2021 | $9,711,000 | +17.9% | 243,852 | +10.1% | 0.02% | +14.3% |
| Q3 2021 | $8,237,000 | +9.3% | 221,390 | +24.1% | 0.01% | +7.7% |
| Q2 2021 | $7,538,000 | +88.0% | 178,390 | +110.6% | 0.01% | +85.7% |
| Q1 2021 | $4,010,000 | +0.3% | 84,716 | +29.2% | 0.01% | -12.5% |
| Q4 2020 | $3,999,000 | +5.8% | 65,564 | -18.9% | 0.01% | 0.0% |
| Q3 2020 | $3,778,000 | -21.9% | 80,842 | -15.2% | 0.01% | -27.3% |
| Q2 2020 | $4,838,000 | +43.9% | 95,377 | +26.5% | 0.01% | +22.2% |
| Q1 2020 | $3,361,000 | -6.0% | 75,417 | +1.2% | 0.01% | +28.6% |
| Q4 2019 | $3,576,000 | +81.1% | 74,489 | +27.5% | 0.01% | +75.0% |
| Q3 2019 | $1,975,000 | +361.4% | 58,401 | +513.3% | 0.00% | +300.0% |
| Q2 2019 | $428,000 | +19.6% | 9,522 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $358,000 | +9.5% | 9,522 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $327,000 | -27.0% | 9,522 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $448,000 | +39.6% | 9,522 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $321,000 | +24.4% | 9,522 | 0.0% | 0.00% | – |
| Q1 2018 | $258,000 | +62.3% | 9,522 | 0.0% | 0.00% | – |
| Q4 2017 | $159,000 | -16.8% | 9,522 | 0.0% | 0.00% | – |
| Q3 2017 | $191,000 | +9.1% | 9,522 | 0.0% | 0.00% | – |
| Q2 2017 | $175,000 | -22.9% | 9,522 | -58.6% | 0.00% | – |
| Q1 2017 | $227,000 | -43.7% | 23,022 | -36.2% | 0.00% | -100.0% |
| Q4 2016 | $403,000 | – | 36,078 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |